The "cross talk" between the receptors of insulin, estrogen and progesterone in neutrophils in the synthesis of maspin through nitric oxide in breast cancer

International Journal of Biomedical Science

Volumn 8, Issue 2, 2012, Pages 129-139

  Halder, Umesh Chandra ^b  

^a Bhattacharjee), Karabi   (India)

^b JADAVPUR UNIVERSITY   (India)

Author keywords

Breast cancer; Crosstalk; Estrogen; Insulin receptor; Maspin; Neutrophils; Nitric oxide; Progesterone; Steroids receptors

Indexed keywords

ESTROGEN; ESTROGEN RECEPTOR; INSULIN; INSULIN RECEPTOR; MASPIN; NITRIC OXIDE; PROGESTERONE; PROGESTERONE RECEPTOR;

ADULT; AGED; ARTICLE; BINDING AFFINITY; BREAST CANCER; CELL ISOLATION; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME SYNTHESIS; ESTROGEN BINDING; FEMALE; HUMAN; HUMAN CELL; INSULIN BINDING; NEUTROPHIL; NONHUMAN; PROTEIN PROTEIN INTERACTION; PROTEIN SYNTHESIS REGULATION; RECEPTOR BINDING;

EID: 84865380031     PISSN: 15509702     EISSN: 15552810     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Freychet P, Roth J, Neville DM Jr. Insulin receptors in the liver: specific binding of (125 I) insulin to the plasma membrane and its relation to insulin bioactivity. Proc. Natl. Acad. Sci. USA. 1971; 68 (8): 1833-1837.
2. Basrawala Z, Alimirah F, Xin H, Mohideen N, et al. Androgen receptor levels are increased by interferons in human prostate stromal and epithelial cells. Oncogene. 2006; 25 (19): 2812-2817.
3. Kahn NN, Sinha AK. Down regulation of alpha 2 adrenergic receptor numbers in platelets by insulin. Biochim. Biophys. Acta. 1992; 1134 (3): 292-296.
4. Dutta-Roy AK, Kahn NN, Sinha AK. Interaction of receptors for prostaglandin E1/prostacyclin and insulin in human erythrocytes and platelets. Life Sci. 1991; 49 (16): 1129-1139.
5. Kahn NN, Bauman WA, Hatcher VB, Sinha AK. Inhibition of platelet aggregation and the stimulation of prostacyclin synthesis by insulin in humans. Am. J. Physiol. 1993; 265 (6 Pt 2): H2160-2167.
6. 1binding to human blood platelet membrane by insulin and the activation of adenylate cyclase. J. Biol. Chem. 1990; 265: 4976-4981.
7. Ganguly (Bhattacharjee) K, Bhattacharyya M, Halder UC, Jana P, et al. The role of neutrophil estrogen receptor status on maspin synthesis via nitric oxide production in human breast cancer. Journal of Breast Cancer. 2012; (In Press).
8. Girish GV, Bhattacharya G, Sinha AK. The role of insulin dependent NO synthesis in the impaired production of maspin in human breast cancer. J. Cancer Res. Clin. Oncol. 2006; 132: 389-398.
9. Motomura K, Ishitobi M, Komoike Y, Koyama H, et al. Expression of estrogen receptor beta and phosphorylation of estrogen receptor alpha serine 167 correlate with progression-free survival in patients with metastatic breast cancer treated with aromatase inhibitors. Oncology. 2010; 79: 55-61.
10. Gelbfish GA, Davidson AL, Kopel S, et al. Relationship of estrogen and progesterone receptors to prognosis in breast cancer. Ann. Surg 1988; 207 (1): 75-79.
11. Tlaskalova-Hogenova H, Stepankova R. Development of antibody formation in germ-free and conventionally reared rabbits: the role of intestinal lymphoid tissue in antibody formation to E. coli antigens. Folia. Biol. (Praha). 1980; 26: 81-93.
12. Cox RD, Frank CW. Determination of nitrate and nitrite in blood and urine by Chemiluminiscence. J. Anal. Toxico. 1982; 6: 148-152.
13. Klock JC, Bainton DF. Degranulation and abnormal bactericidal function of granulocytes procured by reversible adhesion to nylon wool. Blood. 1976; 48: 149-161.
14. Cook L, Ross AM, Knight GB, Agnello V. Use of whole blood specimens for routine clinical quantitation of hepatitis C virus RNA does not increase assay sensitivity. J. Clin. Microbiol. 2000; 38: 4326-4231.
15. Zimmerman R, Paluch U, Sprinzl M, Neupert W. Cell-free synthesis of the mitochondrial ADP/ATP carrier protein of Neurospora crassa. Eur. J. Biochem. 1979; 99: 247-252.
16. Engvall E, Perlmann P. Enzyme-linked immunosorbant assay, ELISA. 3. Quantitation of specific antibodies by enzyme-labeled anti-immunoglobulin in antigen-coated tubes. J. Immunol. 1972; 109: 129-135.
17. Scatchard G. The attractions of proteins for small molecules and ions. Ann. Y. Acad. Sci. 1949; 51: 660-672
18. Wajchenburg BL, Pinto H, TarresdeToledoeSouza I, Lerario AC, et al. Preparation of iodine-125-labelled insulin for radio immunoassay: comparison of lactoperoxidase and chloramine-T iodination. J. Nucl. Med. 1978; 19: 900-905.
19. Czech MP. Molecular basis of insulin action. Annu. Rev. Biochem. 1977; 46: 359-384.
20. Bar RS, Harrison LC, Muggeo M, Gorden P, et al. Regulation of insulin receptors in normal and abnormal physiology in humans. Adv. Intern. Med. 1979; 24: 23-52.
21. McDonnell DP, GoldmanME. RU486 exerts antiestrogenic activities through a novel progesterone receptor A form-mediated mechanism. J. Biol. Chem. 1994; 269 (16): 11945-11949.
22. Cork DM, Lennard TW, Tyson-Capper AJ. Alternative splicing and the progesterone receptor in breast cancer. Breast Cancer Res. 2008; 10 (3): 207.
23. Pichon MF, Pallud C, Brunet M, Milgrom E. Relationship of presence of progesterone receptors to prognosis in early breast cancer. Cancer Res. 1980; 40 (9): 3357-3360.
24. Kiba T, Inamoto T, Nishimura T, et al. The reversal of recurrence hazard rate between ER positive and negative breast cancer patients with axillary lymph node dissection (pathological stage I-III) 3 years after surgery. BMC Cancer. 2008; 8: 323.
25. Hojo T, AkiyamaY, Nagasaki K. Association of maspin expression with the malignancy grade and tumor vascularization in breast cancer tissues. Cancer Lett. 2001; 171: 103-110.
26. Liu T, Pemberton PA, Robertson AD. Three-state unfolding and selfassociation of maspin, a tumor-suppressing serpin. J. Biol. Chem. 1999; 274: 29628-29632.
27. De Meyts P, Van Obberghen E, Roth J. Mapping of the residues responsible for the negative cooperativity of the receptor-binding region of insulin. Nature. 1978; 15; 273 (5663): 504-509.
28. Van den Berg HW, Leahey WJ, Lynch M, Clarke R, et al. Recombinant human interferon alpha increases oestrogen receptor expression in human breast cancer cells (ZR-75-1) and sensitizes them to the antiproliferative effects of tamoxifen. Br. J. Cancer. 1987; 55 (3): 255-257.
29. Abdul Rahman Jazieh, Mohammed Jameel Kyasa, Laura Hutchins. Phase I Clinical Trial of Tamoxifen and Interferon Alpha in the Treatment of Solid Tumors. The Journal of Applied Research. 2004; 4 (3): 464-469.
30. Bhattacharyya M, Karmohapatra SK, Bhattacharya G, Bhattacharya R, et al. The role of leucocytes in the acetyl salicylic acid (aspirin) induced nitric oxide synthesis in the production of interferon-alpha, a potent inhibitor of platelet aggregation and a thrombolytic agent. J. Thromb. Thrombolysis. 2009; 28 (2): 173-184.